Table 2.
Vehicle | Dox | Dox + 4-AN | |
---|---|---|---|
LVEDP, mmHg | |||
WT | 3.5 ± 1.1 | 7.1 ± 0.8* | 4.2 ± 0.5† |
CrmA | 3.1 ± 0.3 | 7.1 ± 0.6* | 3.3 ± 0.5† |
LVSP, mmHg | |||
WT | 107.9 ± 2.2 | 91.24 ± 5.7* | 103.4 ± 3.8† |
CrmA | 111.8 ± 3.2 | 82.3 ± 2.6* | 105.2 ± 6.6† |
dP/dtmax, mmHg/s | |||
WT | 8,693 ± 304 | 6,529 ± 715* | 8,102 ± 461† |
CrmA | 8,896 ± 486 | 5,816 ± 1075* | 8,413 ± 265† |
dP/dtmin, mmHg/s | |||
WT | 7,282 ± 530 | 4,202 ± 480* | 6,914 ± 246† |
CrmA | 6,945 ± 562 | 3,029 ± 548* | 6,026 ± 359† |
CO, ml/min | |||
WT | 5.0 ± 0.4 | 2.8 ± 0.2* | 4.8 ± 0.4† |
CrmA | 5.2 ± 0.5 | 2.3 ± 0.1* | 4.4 ± 0.6† |
τ, ms | |||
WT | 12.4 ± 1.1 | 23.0 ± 4.0* | 13.6 ± 1.2† |
CrmA | 11.5 ± 0.7 | 24.8 ± 2.3* | 14.0 ± 1.2† |
Values are means ± SE; n = 6 to 7 mice. τ, ventricular isovolumic relaxation time constant.
P < 0.05, Dox vs. vehicle;
P < 0.05, Dox vs. Dox + 4-amino-1,8-naphthalimide (4-AN).